journal article·2021-03

Hosting of the antibiotic Vancomycin by bentonite: Characterization and slow release study

S.A. Martín, I. Pérez, A. Rivera

Publisher page

Abstract

Abstract Bentonite (Bent) is a highly promising material to be used in the pharmaceutical industry as drug delivery system due to its high drug loading capacity and controlled drug release properties. The adsorption and controlled release of vancomycin (VCM) ―a glycopeptide antibiotic of large molecular size and structural complexity― on/from an unmodified Bent is reported. The adsorption and release of this drug on/from the Bent―whose safety was demonstrated by in vivo studies―was monitored by ultraviolet (UV) spectroscopy. In order to enhance the VCM loading by the clay, different physical-chemical parameters (pH, drug initial concentration, temperature and interaction time) were evaluated. The Bent-VCM composite was characterized by X-ray diffraction (XRD), transmittance Fourier transform infrared spectroscopy (FT-IR) and thermal gravimetric analysis (TGA). The results showed that the Bent is able to efficiently adsorb VCM, achieving a higher load (qmax= 655 ± 5 mg/g) at 9 × 103 mg/L, when it is in its monovalent cationic form. The characterization studies indicated surface adsorption, as well as clay-drug interactions by hydrogen bridges and electrostatic forces. The Sips isotherm model exhibited a good correlation to the equilibrium experimental data, indicating heterogeneous adsorption of the adsorbate-adsorbent system under study. The ΔG0 calculation indicated the spontaneous and reversible nature of the adsorption process. The in vitro assays at pH values typical of the human gastrointestinal tract demonstrated that the VCM release profiles fulfill the pharmaceutical standards, suggesting the potential use of Bent as VCM carrier.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Clay minerals and soil interactions · Soil and Unsaturated Flow · Therapeutic Uses of Natural Elements

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (80)

Show source-provided references
1. Use of clays as drug delivery systems: possibilities and limitations10.1016/j.clay.2006.06.015 ↗
2. Nonyl-and dodecylamines intercalated bentonite and illite from Turkey
3. The equilibrium and kinetics studies of flurbiprofen adsorption onto tetrabutylammonium montmorillonite (TBAM)10.1016/j.colsurfa.2008.11.009 ↗
4. Aqueous phase adsorption of cephalexin onto bentonite and activated carbon10.1080/01496391003689017 ↗
5. Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vanomycin10.1002/1097-4636(20011205)57:3<321::AID-JBM1174>3.0.CO;2-S ↗
6. Retention of organic molecule “quinalizarin” by bentonitic clay saturated with different cations10.1016/j.desal.2006.03.578 ↗
7. Industrial use of brazilian bentonite modified by mild acid attack
8. A study of equilibrium and FTIR, SEM/EDS analysis of trimethoprim adsorption onto K1010.1016/j.molstruc.2006.04.054 ↗
9. Effect of hydrochloric acid on the structural of sodic-bentonite clay
10. Bergaya · 2006
11. Infrared spectroscopic analyses on the nature of water in montmorillonite10.1346/CCMN.1994.0420606 ↗
12. Recent developments in intercalation compounds: chemistry and applications10.1039/C8DT90035C ↗
13. Surface chemistry and adsorption
14. Characterization and adsorptive properties of pharmaceutical grade clays10.1002/jps.2600690719 ↗
15. Carlson · 2004 · 17
16. Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients10.1016/j.clay.2009.10.016 ↗
17. Invitro studies and evaluation of metformin marketed tablets-Malaysia
18. Clays and clay minerals for pollution control10.1016/S1572-4352(05)01020-2 ↗
19. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
20. The systems containing clays and clay minerals from modified drug release: a review10.1016/j.colsurfb.2012.10.068 ↗
21. Extended-release of chlorpromazine intercalated into montmorillonite clays10.1016/j.micromeso.2018.03.017 ↗
22. A rational explanation of the vancomycin release from SBA-15 and its derivative by molecular modelling10.1016/j.micromeso.2010.04.010 ↗
23. Ciprofloxacin intercalated in fluorohectorite clay: identical pure drug activity and toxicity with higher adsorption and controlled release rate10.1039/C7RA01384A ↗
24. Effects of hydrochloric acid treatment on structure characteristics and C2H4 adsorption capacities of U¨ nye bentonite from Turkey: a combined FT-IR, XRD, XRF, TG/DTA and MAS NMR study10.1007/s10450-016-9768-y ↗
25. Földvári · 2011
26. Insights into modeling of adsorption isotherm systems10.1016/j.cej.2009.09.013 ↗
27. Studies in adsorption. Part XI. A system of classification of solution adsorption isotherms, and its use in diagnosis of adsorption mechanisms and in measurement of specific surface areas of solids10.1039/jr9600003973 ↗
28. Summary of recommendations of nomenclature committees relevant to clay mineralogy: report of the Association Internationale pour L’etude des Argiles (AIPEA) Nomenclature Committee for 200610.1346/CCMN.2006.0540610 ↗
29. Formulation and antibacterial profiles of clay–ciprofloxacin composites10.1016/j.clay.2013.10.020 ↗
30. Synthetic clay mineral as nanocarrier of sulfamethoxazole and trimethoprim10.1016/j.clay.2018.03.016 ↗
31. Organo-modified bentonite for gentamicin topical application: Interlayer structure and in vivo skin permeation10.1016/j.clay.2018.03.029 ↗
32. Investigation of bentonite clay surface as a physical antidote in adsorption of amitriptyline-HCl, chlorpromazine-HCl and chlordiazepoxide-HCl from solution
33. Intercalation chemistry
34. Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles10.1016/j.colsurfb.2014.02.045 ↗
35. Experimental study of montmorillonite structure and transformation of its properties under treatment with inorganic acid solutions
36. Equilibrium isotherm studies of adsorption of pigments extracted from Kuduk-kuduk (Melastoma malabathricum L.) pulp onto TiO2 nanoparticles10.1155/2014/468975 ↗
37. The multi-mechanisms and interlayer configurations of metoprolol uptake on montmorillonite10.1016/j.cej.2018.11.230 ↗
38. Comparison of adsorption equilibrium and kinetic models for a case study of pharmaceutical active ingredient adsorption from fermentation broths: parameter determination, simulation, sensitivity analysis and optimization10.1590/S0104-66322012000300020 ↗
39. Equilibrium and kinetics of vancomycin adsorption on polymeric adsorbent10.1002/aic.12559 ↗
40. Parkia speciosa (Petai) pod as a potential low-cost adsorbent for the removal of toxic crystal violet dye
41. Is the free energy change of adsorption correctly calculated?10.1021/je800661q ↗
42. Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability
43. FTIR techniques in clay mineral studies10.1016/S0924-2031(02)00065-6 ↗
44. Comparative FT-IR study of structural modifications during acid treatment of dioctahedral smectites and hectorite10.1016/S1386-1425(98)00040-7 ↗
45. Natural clay from Cuba for environmental remediation10.1180/clm.2018.13 ↗
46. Structural Momdification of a lamellar solid by thermal treatment. Effect on the Cd and Pb adsorptions from aqueous solution10.1016/j.mspro.2012.06.024 ↗
47. Influence of thermal treatment on bentonite used as adsorbent for Cd, Pb, Zn retention from mono-solute and poly-solute aqueous solutions10.1590/S1516-14392012005000074 ↗
48. Waste-derived activated carbons for removal of ibuprofen from solution: role of surface chemistry and pore structure10.1016/j.biortech.2008.09.039 ↗
49. Mineralogy-Database
50. Anionic clays containing anti-inflammatory drug molecules: comparison of molecular dynamics simulation and measurements10.1021/jp050480m ↗
51. Effect of acid activation on structural and bleaching properties of a bentonite
52. Structure and composition of the clay minerals and their physical and chemical properties10.1016/S1572-4352(06)02002-2 ↗
53. Effects of bentonite on different cell types: a brief review10.1016/j.clay.2014.12.036 ↗
54. OECD · 2001 · 24
55. OECD/OCDE-423
56. Controlled release of donepezil intercalated in smectite clays10.1016/j.ijpharm.2008.04.012 ↗
57. Antimicrobial properties of tetracycline and minocycline-montmorillonites10.1016/j.clay.2010.05.005 ↗
58. Uptake of lead by Na-exchanged and Al-pillared bentonite in the presence of organic acids with different functional groups10.1016/j.clay.2015.11.004 ↗
59. Pérez · 2013
60. Adsorption and intercalation of tetracycline by swelling clay minerals10.1016/j.clay.2009.07.002 ↗
61. Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E ↗
62. Intercalation of metformin into montmorillonite10.1039/C7DT04197G ↗
63. Smectite as ciprofloxacin delivery system: Intercalation and temperature-controlled release properties10.1016/j.clay.2016.02.006 ↗
64. Adsorption of promethazine hydrochloride with KSF montmorillonite10.1007/s10450-006-0141-4 ↗
65. Characterization of minerals, metals, and materials
66. Stuart · 2004
67. Molecular dynamics study of montmorillonite crystalline swelling: roles of interlayer cation species and water content10.1016/j.chemphys.2015.04.005 ↗
68. Acid-base properties and proton-speciation of vancomycin10.1016/0378-5173(93)90252-B ↗
69. Modification of smectite structure by sulfuric acid and characteristics of the modified smectite10.2298/JAS1101025T ↗
70. Removal of malachite green from aqueous solution using low-cost chlorella-based biomass10.1016/j.jhazmat.2009.10.087 ↗
71. United States Pharmacopeial, C · 2007
72. Incorporation of tramadol drug into Li-Fuorohectorite clay: a preliminary study of a medical nanofuid10.1140/epjst/e2015-50323-x ↗
73. Glycopeptide-clay nanocomposite: chemical-physical characterization
74. A simple way for targeted delivery of an antibiotic: in vitro evaluation of a nanoclay-based composite10.1371/journal.pone.0187879 ↗
75. Wallace · 2014
76. Single wall carbon nanohorn as a drug carrier for controlled release10.1016/j.cplett.2008.06.077 ↗
77. Preparation and evaluation of vancomycin-loaded N-trimethyl chitosan nanoparticles10.3390/polym7091488 ↗
78. Physicochemical characterization of vancomycin and its complexes with β-cyclodextrin
79. Study on ibuprofen/montmorillonite intercalation composites as drug release system10.1016/j.clay.2007.01.012 ↗
80. Effect of thermal treatment on the bentonite properties